K2 Principal Fund, L.P. Biomarin Pharmaceutical Inc Call Options Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $2.27 Million - $2.54 Million	-30,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1.12 Million - $1.36 Million	15,000 Added 100.0%	30,000 $2.27 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $1.09 Million - $1.35 Million	15,000 New	15,000 $1.32 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.